NCT00559936View on ClinicalTrials.gov

Topical Avastin for Treatment of Corneal Neovascularization

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Corneal Neovascularization
Interventions
DRUG

Topical Avastin 1%

Avastin (bevacizumab) 1%

Trial Locations (1)

02114

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT00559936 - Topical Avastin for Treatment of Corneal Neovascularization | Biotech Hunter | Biotech Hunter